Ammonium Chloride/ Diphenhydramine
Indications
Registered South African indications:
- Cough
Cautions
Combination products may have additional pharmacological effects not accounted for by the action of the individual ingredients
Ammonium chloride
Contraindications
- Hypersensitivity to the active ingredient or any of the excipients in this combination product
- Severe renal impairment
- Severe hepatic impairment
- Metabolic alkalosis
Cautions
- Pregnancy
- Breastfeeding
- Mild to moderate renal impairment
- Mild to moderate hepatic impairment
- Respiratory insufficiency
Diphenhydramine
Contraindications
- Hypersensitivity to the active ingredient or any of the excipients in this combination product
- Asthma
- Narrow angle glaucoma
- Prostatic hypertrophy
- Stenosing peptic ulcer
- Pyloroduodenal obstruction
- Bladder neck obstruction
- Porphyria
Cautions
- Breastfeeding
- Moderate to severe renal impairment
- Hepatic impairment
- Elderly
- Glaucoma
- Urinary retention
- Myasthenia gravis
- Epilepsy
- Bronchitis
- Chronic obstructive pulmonary disease
- Tinnitus
- Prolonged use
Adult dosage
Forms avail. in SA and covered in this monograph: syr
Relief of cough
Ammonium Chloride/ Diphenhydramine
125/12.5 (mg/5ml)
- Oral (syr): 5-10ml, 3-4 hrly; Max: 40ml/24hrs
Paediatric dosage
Paed. forms avail. in SA and covered in this monograph: syr
Relief of cough
Ammonium Chloride/ Diphenhydramine
125/12.5 (mg/5ml)
- Younger than 6: Not established for use
- Between 6-12 years: Oral (syr): 2.5-5ml, 4hrly; Max: 20ml/24hrs
- Older than 12 years: See adult dosage
Special populations
Recommendations for this combination product as per highest risk category when comparing individual active ingredients
Pregnancy
- Caution (Ammonium chloride, Diphenhydramine)
- The safety of ammonium chloride during pregnancy has not been established, although there is no good evidence of an association between first-trimester exposure to ammonium chloride and foetal abnormalities
- Diphenhydramine crosses the placenta. Because animal reproduction studies are not always predictive of human response and since there is inadequate experience with the use of diphenhydramine in pregnant women, the potential risk for humans is unknown. Use of sedating antihistamines during the third trimester may result in reactions in the newborn or premature neonates. This agent is not recommended during pregnancy
Breastfeeding
- Caution; not recommended (Diphenhydramine)
- Diphenhydramine has been detected in breast milk, but the effect of this on breastfed infants is unknown. Diphenhydramine is not recommended for use during lactation in nursing mothers
- The safety of ammonium chloride during lactation has not been established, although use during this period would not be considered to constitute a hazard
Renal Impairment
- Mild to moderate: Caution; no dose adjustment recommended (Ammonium chloride)
- Severe: Contraindicated (Ammonium chloride)
Hepatic Impairment
- Mild to moderate: Caution; no dose adjustment recommended (Ammonium chloride)
- Severe: Contraindicated (Ammonium chloride)
Elderly
Porphyria Information
Drugs in Sport
- Permitted - No warnings
Adverse reactions
Combination products may have additional pharmacological effects not accounted for by the action of the individual ingredients
Ammonium chloride
Central Nervous System Disorders
- Coma
- Confusion
- Seizures
- Fever
Gastrointestinal Disorders
- Gastrointestinal discomfort
- Nausea and vomiting
Diphenhydramine
Central Nervous System Disorders
- Sedation
- Disturbances in attention
- Unsteadiness
- Dizziness
- Seizures
- Headache
- Paraesthesia
- Dyskinesias
- Fatigue
- Confusion
- Paradoxical excitement
Cardiovascular Disorders
- Tachycardia
- Palpitations
Respiratory Disorders
- Dyspnoea
- Thickening of bronchial secretions
Gastrointestinal Disorders
- Dry mouth
- Nausea and vomiting
Genitourinary Disorders
- Urinary difficulty
- Urinary retention
Musculoskeletal Disorders
- Muscle twitching
Immune, Blood and Lymphatic System Disorders
- Hypersensitivity reactions
- Urticaria
- Angioedema
Sensory Disorders
- Blurred vision
- Tinnitus
Interactions
Combination products may have additional pharmacological effects not accounted for by the action of the individual ingredients
Ammonium chloride
- Potassium-sparing diuretics
Diphenhydramine
- Central nervous system depressants
- Monoamine oxidase inhibitors
- Anticholinergic agents
- CYP2D6 substrates
Monitoring
None routine
Mechanism of action
Ammonium chloride
Ammonium chloride is used as an expectorant. It causes irritation of the bronchial mucosa, which results in the production of excess respiratory tract fluid. This allows for easier mucus expulsion due to its decreased viscosity.
Diphenhydramine
Diphenhydramine is a histamine H1-receptor antagonist that competes with free histamine for binding at histamine receptors. In addition to its usual anti-allergy actions, it also has significant sedative and antimuscarinic properties.
Dosage forms
- Syrup
- Liquid
Formulation
COMBINATION PREPARATIONS
Ammonium Chloride/ Diphenhydramine
Syrup (per 5ml) 125mg/12.5mg
- Benylin Original (Johnson & Johnson) originator
- Diphal Expectorant (MDI Healthcare)
- Expectalin (Johnson & Johnson) originator
References
1. https://drive.google.com/drive/folders/1qNwFYoPB13VH-12vNRo2wL-w-0qIjXR3 (2/10/1974_J&J_Benylin original_syrup) 2. https://drive.google.com/drive/folders/1qNwFYoPB13VH-12vNRo2wL-w-0qIjXR3 (20/09/1993_J&J_Expectalin_syr) 3. Ammonium chloride monograph; Accessed online; 14 Nov 2018 https://cms.emguidance.com/medicine-edit/118aa5c7-0b1a-4af8-b4a4-c2210d4071d8 4. Diphenhydramine monograph; Accessed online; 14 Nov 2018 https://cms.emguidance.com/medicine-edit/d744674e-d9e7-4857-9ef2-16a8da8aeb2d 5. NAPOS The Drug Database for Acute Porphyria: Ammonium chloride, Diphenhydramine; Accessed online 14 Nov 2018 http://www.drugs-porphyria.org/languages/UnitedKingdom/s3.php?atc_code=R06AA52&l=gbr 6. South African Institute for Drug-Free Sport: Expectalin; Accessed online 14 Nov 2018 [http://www.drugfreesport.org.za/online-medication-check]
Brands & products
11 products · cached snapshot- Benylin Original
- Diphal Expectorant
- Expectalin
SYRSyrup· 6 products
from R9.69| Product | Strength | Pack | Applicant | Min price |
|---|---|---|---|---|
| Tusquit Elixirdiscontinued | 125 mg/5ml;mg/5ml | 100 | Xixia Pharmaceuticals (Pty) Ltd | R9.69 |
| Diphal Expectorant | 136 mg/5ml;mg/5ml | 100 | Medicine Developers International Healthcare cc | R10.45 |
| Tusquit Elixirdiscontinued | 125 mg/5ml;mg/5ml | 200 | Xixia Pharmaceuticals (Pty) Ltd | R19.35 |
| Diphal Expectorant | 136 mg/5ml;mg/5ml | 200 | Medicine Developers International Healthcare cc | R20.99 |
| Benylin Original | 125 mg/5ml;mg/5ml | 100 | Johnson & Johnson (Pty) Ltd | R56.11 |
| Benylin Original | 125 mg/5ml;mg/5ml | 200 | Johnson & Johnson (Pty) Ltd | R112.26 |
LIQLiquid· 5 products
from R32.69| Product | Strength | Pack | Applicant | Min price |
|---|---|---|---|---|
| Expectalin | 125 mg/5ml;mg/5ml | 100 | Johnson & Johnson (Pty) Ltd | R32.69 |
| Diphenhydramine Expect | 170 mg/5ml;mg/5ml | 2500 | Allied Drug Company | R61.61 |
| Expectalin | 125 mg/5ml;mg/5ml | 200 | Johnson & Johnson (Pty) Ltd | R65.48 |
| Benylin Childrens | 125 mg/5ml;mg/5ml | 200 | Johnson & Johnson (Pty) Ltd | R70.56 |
| Diphenhydramine Expect | 170 mg/5ml;mg/5ml | 20000 | Allied Drug Company | R492.90 |
Medical aid coverage
data not yet integrated- Comprehensive Series—
- Executive Plan—
- KeyCare Series—
- Priority Series—
- Saver Series—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- BonClassic—
- BonComprehensive—
- BonEssential—
- BonFit Select—
- BonSave—
- BonStart—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Beryl—
- Emerald—
- Onyx—
- Ruby—
- Sapphire—
- Tanzanite One—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Aquarium Option—
- Efficiency Option—
- Marine Option—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.